Press Releases

Study results provide positive data for ongoing human trials Reading and Oxford, UK, January 23, 2014 – Clasado, the manufacturers and suppliers of the second generation prebiotic Bimuno®, and The Department of Psychiatry, University of Oxford, today announce...

Canada-based Domain Therapeutics NA Inc. will focus exclusively on leveraging the BioSens-All(TM) technologyStrasbourg, France and Montreal, Canada, January 20, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled...

NanoLogix Inc. an innovator in the rapid detection identification and determination of antibiotic resistance and sensitivity of live bacteria announces that the State of Ohio Department of Economic Development’s International Trade Assistance Center (ITAC) based at Youngstown State University...

Strasbourg, France and Montreal, Canada, January 20, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces the opening of its North American...

Otsuka Pharmaceutical Co. Ltd. (Head office: Chiyoda-ku Tokyo; President Representative Director: Taro Iwamoto) signed a partnership agreement with the Olympic Council of Asia (OCA) for the 2014 Incheon Asian Games (Korea) and the 2019 Hanoi Asian Games (Vietnam) during...

Arcadia Biosciences Inc. and Genective S.A. a joint venture between Group LIMAGRAIN and Group KWS today announced that they have signed an agreement that will allow Genective to develop new corn hybrids incorporating Arcadia’s Water Use Efficiency (WUE) technology....

Adocia, a biotechnology company specializing in the development of ‘best-in-class’ medicines from already approved therapeutic molecules, in particular proteins and oncologic drugs, announces today that it has been granted two patents. The first patent is...